Efficacy and safety of the dual SGLT1 and 2 inhibitor sotagliflozin in combination with a mineralocorticoid receptor antagonist in patients hospitalized for worsening heart failure

被引：0
|
作者：
Pitt, B. [1 ]
Bhatt, D. L. [2 ]
Szarek, M. [3 ]
Davies, M. [4 ]
Banks, P. [4 ]
Steg, P. G. [5 ]
机构：
[1] Univ Michigan, Ann Arbor, MI USA
[2] Icahn Sch Med Mt Sinai, New York, NY USA
[3] Univ Colorado, Sch Med, Aurora, CO USA
[4] Lexicon Pharmaceut Inc, The Woodlands, TX USA
[5] Univ Paris Diderot, Bichat Hosp, INSERM, FACT French Alliance Cardiovasc T,UMR1148, Paris, France
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2023年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：192 / 193
页数：2
相关论文
共 50 条
  • [41] The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial
    Adriaan A. Voors
    Christiane E. Angermann
    John R. Teerlink
    Sean P. Collins
    Mikhail Kosiborod
    Jan Biegus
    João Pedro Ferreira
    Michael E. Nassif
    Mitchell A. Psotka
    Jasper Tromp
    C. Jan Willem Borleffs
    Changsheng Ma
    Joseph Comin-Colet
    Michael Fu
    Stefan P. Janssens
    Robert G. Kiss
    Robert J. Mentz
    Yasushi Sakata
    Henrik Schirmer
    Morten Schou
    P. Christian Schulze
    Lenka Spinarova
    Maurizio Volterrani
    Jerzy K. Wranicz
    Uwe Zeymer
    Shelley Zieroth
    Martina Brueckmann
    Jonathan P. Blatchford
    Afshin Salsali
    Piotr Ponikowski
    Nature Medicine, 2022, 28 : 568 - 574
  • [42] LX4211, a dual inhibitor of SGLT2 and SGLT1 enhances the effects of sitagliptin in patients with type 2 diabetes mellitus
    Zambrowicz, B.
    Ogbaa, I.
    Powell, D.
    Banks, P.
    Turnage, A.
    Frazier, K.
    Boehm, K. A.
    Freiman, J.
    Lapuerta, P.
    Ruff, D.
    Sands, A.
    DIABETOLOGIA, 2012, 55 : S318 - S318
  • [43] Mineralocorticoid Receptor Antagonist Use in Hospitalized Patients With Heart Failure, Reduced Ejection Fraction, and Diabetes Mellitus (from the EVEREST Trial)
    Vaduganathan, Muthiah
    Dei Cas, Alessandra
    Mentz, Robert J.
    Greene, Stephen J.
    Khan, Sadiya
    Subacius, Haris P.
    Chioncel, Ovidiu
    Maggioni, Aldo P.
    Konstam, Marvin A.
    Senni, Michele
    Fonarow, Gregg C.
    Butler, Javed
    Gheorghiade, Mihai
    AMERICAN JOURNAL OF CARDIOLOGY, 2014, 114 (05): : 743 - 750
  • [44] LX4211, a dual SGLT1/SGLT2 inhibitor shows a favourable gastrointestinal and genitourinary safety profile in type 2 diabetes mellitus patients and healthy subjects
    Freiman, J.
    Ye, G. -L.
    Ogbaa, I.
    Boehm, K. A.
    Turnage, A.
    Frazier, K.
    Sands, A.
    Zambrowicz, B.
    DIABETOLOGIA, 2012, 55 : S318 - S319
  • [45] LEVERAGING EHR ALERTS AND PHARMACISTS TO ACCELERATE SGLT2 INHIBITOR PRESCRIBING IN HOSPITALIZED PATIENTS WITH HEART FAILURE
    Nguyen, Diana
    Kuo, Ruth
    Evenstad, Amy
    Cordero, Kelly
    Jaravata, Ashley
    Mccoy, Ruth
    Nowaczyk, Jennifer
    Park, Joshua J.
    Lew, Michelle
    Mohan, Rajeev
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 278 - 278
  • [46] The Impact of LX4211, a Dual Inhibitor of Sodium Glucose Transporters SGLT1 and SGLT2, on Blood Pressure in Patients With Type 2 Diabetes
    Lapuerta, Pablo
    Neutel, Joel
    Zambrowicz, Brian
    Ogbaa, Ike
    Banks, Phillip
    Frazier, Kenny
    Sands, Arthur
    DIABETES, 2013, 62 : A62 - A62
  • [47] LX4211, a dual inhibitor of sodium glucose transporters SGLT1 and SGLT2, reduces blood pressure in patients with type 2 diabetes
    Lapuerta, P.
    Neutel, J.
    Zambrowicz, B.
    Ogbaa, I.
    Banks, P.
    Frazier, K.
    Sands, A.
    DIABETOLOGIA, 2013, 56 : S380 - S380
  • [48] The SGLT2 Inhibitor Empagliflozin in Patients Hospitalized for Acute Heart Failure a Multinational Randomized Trial (The EMPULSE Trial)
    Sardar, Souvik
    JOURNAL OF THE PRACTICE OF CARDIOVASCULAR SCIENCES, 2022, 8 (02) : 77 - 78
  • [49] Meta-analysis of sotagliflozin, a dual sodium-glucose-cotransporter 1/2 inhibitor, for heart failure in type 2 diabetes
    Bantounou, Maria Anna
    Sardellis, Panagiotis
    Plascevic, Josip
    Awaes-Mahmood, Ribeya
    Kaczmarek, Justyna
    Boada, Daniel Black
    Thuemmler, Rosa
    Philip, Sam
    ESC HEART FAILURE, 2025, 12 (02): : 968 - 979
  • [50] Hemodynamic and clinical effects of tezosentan, an intravenous dual endothelin receptor antagonist, in patients hospitalized for acute decompensated heart failure
    Torre-Amione, G
    Young, JB
    Colucci, WS
    Lewis, BS
    Pratt, C
    Cotter, G
    Stangl, K
    Elkayam, U
    Teerlink, JR
    Frey, A
    Rainisio, M
    Kobrin, I
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 42 (01) : 140 - 147
12345